Researchers at the Miguel Institute, supported by the Ministry of Science and Technology, explain the research at a press conference. They claim the vaccine’s efficacy has been proven in preclinical trials, and that the virus in poultry has a high genetic identity to the human virus and can be adapted within three months for human testing.